Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Iridex Cp (IRIX)

Iridex Cp (IRIX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 27,516
  • Shares Outstanding, K 13,758
  • Annual Sales, $ 42,600 K
  • Annual Income, $ -12,810 K
  • 60-Month Beta 0.90
  • Price/Sales 0.73
  • Price/Cash Flow N/A
  • Price/Book 1.22

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.17
  • Number of Estimates 2
  • High Estimate -0.16
  • Low Estimate -0.19
  • Prior Year -0.26
  • Growth Rate Est. (year over year) +34.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.84 +16.56%
on 09/16/19
2.90 -26.04%
on 08/21/19
-0.54 (-19.97%)
since 08/16/19
3-Month
1.84 +16.56%
on 09/16/19
5.34 -59.84%
on 06/18/19
-2.72 (-55.87%)
since 06/17/19
52-Week
1.84 +16.56%
on 09/16/19
7.22 -70.30%
on 09/18/18
-4.18 (-66.06%)
since 09/17/18

Most Recent Stories

More News
MicroPulse(R) Transscleral Laser Therapy Will be Discussed in Various Presentations and Educational Events at ESCRS 2019 in Paris, France

IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today that its patented MicroPulse(R) laser...

IRIX : 2.12 (+6.00%)
Ophthalmic Lasers Market 2019 to Witness Excellent Long-Term Growth Outlook

The Global Ophthalmic Lasers Market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2019 to 2026.

VRX.TO : 30.80 (-3.33%)
ABT : 83.59 (+0.28%)
ELXMF : 0.4300 (+2.38%)
IRIX : 2.12 (+6.00%)
NVS : 86.62 (+0.56%)
QUTEF : 16.3561 (+1.72%)
TOPCF : 13.5100 (+0.82%)
Iridex (IRIX) Reports Q2 Loss, Lags Revenue Estimates

Iridex (IRIX) delivered earnings and revenue surprises of 18.18% and -4.70%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

IRIX : 2.12 (+6.00%)
Iridex: 2Q Earnings Snapshot

MOUNTAIN VIEW, Calif. (AP) _ Iridex Corp. (IRIX) on Tuesday reported a loss of $2.4 million in its second quarter.

IRIX : 2.12 (+6.00%)
IRIDEX Announces 2019 Second Quarter Financial Results

IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the second quarter ended June 29, 2019.

IRIX : 2.12 (+6.00%)
Iridex (IRIX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Iridex (IRIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

IRIX : 2.12 (+6.00%)
IRIDEX to Report Second Quarter 2019 Financial Results on August 6, 2019

IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the second quarter of 2019 after the close of trading on Tuesday, August 6, 2019. The Company's management...

IRIX : 2.12 (+6.00%)
Ophthalmic Lasers Market: Huge Growth Opportunities and Challenges to Watch in 2019

VRX.TO : 30.80 (-3.33%)
ABT : 83.59 (+0.28%)
ELXMF : 0.4300 (+2.38%)
IRIX : 2.12 (+6.00%)
NVS : 86.62 (+0.56%)
QUTEF : 16.3561 (+1.72%)
TOPCF : 13.5100 (+0.82%)
Iridex (IRIX) Reports Q1 Loss, Tops Revenue Estimates

Iridex (IRIX) delivered earnings and revenue surprises of 8.33% and 1.34%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

IRIX : 2.12 (+6.00%)
Iridex: 1Q Earnings Snapshot

MOUNTAIN VIEW, Calif. (AP) _ Iridex Corp. (IRIX) on Thursday reported a loss of $3 million in its first quarter.

IRIX : 2.12 (+6.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More Share

Trade IRIX with:

Business Summary

IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors....

See More

Key Turning Points

2nd Resistance Point 2.47
1st Resistance Point 2.23
Last Price 2.12
1st Support Level 1.80
2nd Support Level 1.61

See More

52-Week High 7.22
Fibonacci 61.8% 5.16
Fibonacci 50% 4.53
Fibonacci 38.2% 3.90
Last Price 2.12
52-Week Low 1.84

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar